Nordic Capital Evolution Fund to partner with Minerva Imaging, to support its growth journey in the radiopharmaceutical space
Minerva Imaging (“Minerva”) is a market-leading, science-driven Contract Research Organisation (“CRO”) and Contract Development and Manufacturing Organisation (“CDMO”), specialising in the development of targeted radioligand therapies — a fast-emerging and transformative field within cancer therapeutics. The partnership will support Minerva’s growth journey and ambition to build a global market-leading radiopharmaceutical platform With deep expertise […]
Read more